Literature DB >> 2470920

Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein.

H C Ertl1, B Dietzschold, M Gore, L Otvos, J K Larson, W H Wunner, H Koprowski.   

Abstract

The T-helper cell response to the internal proteins of rabies virus was investigated. The rabies virus nucleoprotein was shown to be a major target antigen for T-helper cells that cross-react between rabies and rabies-related viruses. T-helper cells were assayed in vitro by testing virus-induced lymphocytes for lymphokine secretion in response to antigen. Immunodominant T-helper cell epitopes of the viral nucleoprotein were identified in vitro by using synthetic peptides delineated from the amino acid sequence of the nucleoprotein. The response to synthetic peptides were under Ir gene control. Antigenic peptides were tested in vivo for stimulation of rabies virus-specific T-helper cells. Inoculation of mice with peptides bearing immunodominant T-helper cell epitopes resulted in an accelerated and enhanced neutralizing antibody response upon booster immunization with inactivated rabies virus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470920      PMCID: PMC250834     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Generation of cytolytic T lymphocytes in vitro. IX. induction of secondary CTL responses in primary long-term MLC by supernatants from secondary MLC.

Authors:  J E Ryser; J C Cerottini; K T Brunner
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

Review 2.  The molecular biology of rabies viruses.

Authors:  W H Wunner; J K Larson; B Dietzschold; C L Smith
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

Review 3.  Empirical predictions of protein conformation.

Authors:  P Y Chou; G D Fasman
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  Rabies group-specific ribonucleoprotein antigen and a test system for grouping and typing of rhabdoviruses.

Authors:  L G Schneider; B Dietzschold; R E Dierks; W Matthaeus; P J Enzmann; K Strohmaier
Journal:  J Virol       Date:  1973-05       Impact factor: 5.103

5.  Induction and biological properties of defective interfering particles of rabies virus.

Authors:  T J Wiktor; B Dietzschold; R N Leamnson; H Koprowski
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

6.  Chemical and immunological analysis of the rabies soluble glycoprotein.

Authors:  B Dietzschold; T J Wiktor; W H Wunner; A Varrichio
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

7.  Immunogenicity of a synthetic HBsAg peptide: enhancement by conjugation to a fatty acid carrier.

Authors:  T P Hopp
Journal:  Mol Immunol       Date:  1984-01       Impact factor: 4.407

8.  Recovery from experimental rabies by adoptive transfer of immune cells.

Authors:  B S Prabhakar; H R Fischman; N Nathanson
Journal:  J Gen Virol       Date:  1981-09       Impact factor: 3.891

9.  Rabies virus glycoprotein. II. Biological and serological characterization.

Authors:  J H Cox; B Dietzschold; L G Schneider
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

10.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

Authors:  H Takahashi; J Cohen; A Hosmalin; K B Cease; R Houghten; J L Cornette; C DeLisi; B Moss; R N Germain; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

View more
  33 in total

1.  Insect peptides with improved protease-resistance protect mice against bacterial infection.

Authors:  L Otvos; K Bokonyi; I Varga; B I Otvos; R Hoffmann; H C Ertl; J D Wade; A M McManus; D J Craik; P Bulet
Journal:  Protein Sci       Date:  2000-04       Impact factor: 6.725

2.  Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells.

Authors:  J K Larson; L Otvos; H C Ertl
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

3.  Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes.

Authors:  J T Roehrig; A J Johnson; A R Hunt; B J Beaty; J H Mathews
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

4.  Conserved nucleotide sequence of rabies virus cDNA encoding the nucleoprotein.

Authors:  K Mannen; K Hiramatsu; K Mifune; S Sakamoto
Journal:  Virus Genes       Date:  1991-01       Impact factor: 2.332

5.  Genetic characterization of rabies virus isolates in Korea.

Authors:  Yoo Jin Park; Myung Kyun Shin; Hyuk Moo Kwon
Journal:  Virus Genes       Date:  2005-05       Impact factor: 2.332

6.  Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine.

Authors:  B Dietzschold; M Gore; D Marchadier; H S Niu; H M Bunschoten; L Otvos; W H Wunner; H C Ertl; A D Osterhaus; H Koprowski
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

7.  Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells.

Authors:  J K Larson; W H Wunner; L Otvos; H C Ertl
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus.

Authors:  J H Mathews; J E Allan; J T Roehrig; J R Brubaker; M F Uren; A R Hunt
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  The free nucleocapsids of the viral haemorrhagic septicaemia virus contain two antigenically related nucleoproteins.

Authors:  B Basurco; F Sanz; M A Marcotegui; J M Coll
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

10.  Expression of the nucleoprotein of rabies virus in Escherichia coli and mapping of antigenic sites.

Authors:  H Goto; N Minamoto; H Ito; T R Luo; M Sugiyama; T Kinjo; A Kawai
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.